How LDL Helps Deliver Cancer Treatment
Author Information
Author(s): B.A. Allison, P.H. Pritchard, J.G. Levy
Primary Institution: University of British Columbia
Hypothesis
Receptor-mediated endocytosis of BPD-LDL complexes might be an important mechanism in the selective accumulation of this photosensitiser in tumour tissue.
Conclusion
The LDL receptor is responsible for the accumulation of LDL-associated BPD both in vitro and in vivo, suggesting that this delivery system may improve photodynamic therapy in clinical practice.
Supporting Evidence
- LDL receptor-negative fibroblast cell lines showed insignificant accumulation of BPD compared to normal cell lines.
- Chemical acetylation of LDL markedly decreased the uptake of BPD-LDL.
- LDL receptor-mediated endocytosis was confirmed by comparing the accumulation of BPD-LDL and BPD-['251I]LDL.
Takeaway
This study shows that a special protein called LDL helps deliver a cancer treatment to tumors, making it work better.
Methodology
The study involved in vitro experiments with fibroblast and M-1 tumour cell lines, as well as in vivo studies in mice to assess the accumulation of BPD-LDL.
Limitations
The study does not explore the interaction of photosensitisers with extracellular matrix components.
Participant Demographics
The study involved human fibroblast cell lines and DBA/2J mice.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website